Inactive Instrument

All News InterMune Inc

Equities

US45884X1037

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2014	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
2014	Roche : rules out mega deals, open to smaller ones - paper	RE

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	14-10-02	PU
CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	14-09-16	RE
InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	14-09-05	PR
Roche : rules out mega deals, open to smaller ones - paper	14-09-04	RE
Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	14-08-27	RE
InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	14-08-27	PR
InterMune : Ryan & Maniskas, LLP : Announces Investigation of InterMune, Inc.	14-08-26	PR
Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	14-08-25	RE
InterMune : Newman Ferrara LLP : Announces Investigation of InterMune, Inc.	14-08-25	BU
CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	14-08-25	RE
InterMune : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of InterMune, Inc. Stockholders	14-08-24	BU
InterMune : Reports Second Quarter 2014 Financial Results and Business Highlights	14-08-06	PU
InterMune : to Release Second Quarter Financial Results on August 6	14-07-28	PR
InterMune : Receives FDA Breakthough Therapy Designation For Pirfenidone, An Investigational Treatment For IPF	14-07-17	PR
InterMune : Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF	14-05-27	PU
InterMune : Announces Additional Pirfenidone Data in Idiopathic Pulmonary Fibrosis	14-05-20	PU
InterMune : Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine	14-05-18	PU
InterMune : Announces Expanded Access Program for Pirfenidone to Treat Idiopathic Pulmonary Fibrosis (IPF) in the United States	14-05-16	PR
InterMune : Announces Upcoming Data Presentations at 2014 American Thoracic Society Meeting	14-05-12	PU
InterMune : Reports First Quarter 2014 Financial Results, Clinical Development and Business Highlights	14-05-01	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News InterMune Inc

Equities

US45884X1037

All News

Filters